secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImageneBio, Inc. (IMA)
CIK:        0001835579
Form:       8-K
Filed at:   2021-11-10T23:59:59+00:00
Accession:  0001193125-21-326102
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ikena Oncology updates corporate presentation; no specific new data in filing body
--------------------------------------------------------------------------------

- Company updated its corporate presentation on Nov 10, 2021, furnished as Exhibit 99.1.
- Presentation will be posted on the investor relations section of Ikena's website.
- No financial or pipeline specifics are disclosed in the 8-K text itself.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835579/000119312521326102/0001193125-21-326102-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835579/000119312521326102/d254576d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-326102

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer